Type(s) of Cancer
Multiple Myeloma
Multiple Myeloma
Study Phase
Phase 3
Study Completion Date
January 2014
January 2014
NCT00602641Uploaded 03-06-2018
Access via NCI by Request
PDS UID: nci-data-354
An Intergroup Phase III Randomized Controlled Trial Comparing Melphalan, Prednisone and Thalidomide (MPT) Versus Melphalan, Prednisone and Lenalidomide (Revlimid(TM))(MPR) in Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for High-Dose Therapy
Files: NCT00602641-D3
Data DictionaryNCT00602641-D3-Data-Dictionary.pdf
DATANCT00602641-D3-Dataset.csv
OTHERREADME.pdf
Files: NCT00602641-D2
Data DictionaryNCT00602641-D2-Data-Dictionary.pdf
DATANCT00602641-D2-Dataset.csv
OTHERREADME.pdf
Files: NCT00602641-D1
Data DictionaryNCT00602641-D1-Data-Dictionary.pdf
DATANCT00602641-D1-Dataset.csv
OTHERREADME.pdf